Leverkusen W-5090, Germany; Parent of Bayer Corp. (U.S.); acquired Schering AG in spring 2006; In April 2005, Talecris Biotherapeutics Inc., a subsiary of NPS BioTherapeutics Inc., acquired Bayer’s plasma products business, but this did not include Bayer’s recombinant hemophilia products, and Bayer AG still markets Talecris products internationally; Bayer acquired Schering AG in Spring 2006 and renamed the merged company Bayer Schering Pharma, with its U.S. subsidiary (formed from merger of Bayer’s U.S. subsidiary) and Berlex Labs. (Schering AG’s U.S. subsidiary) renamed Bayer HealthCare Pharmaceuticals; In Nov . 2010, the company, then known as Bayer Schering, decided to use the name “Bayer HealthCare”
